skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi. In virtually every other publicly traded company I own or have owned, the CEO owns shares of the company. But in this case, John Proctor has been CEO for three years now and makes $400,000/year yet he owns zero shares? Why is this the case? Is it not a really bad signal that the CEO is giving a presentation on Monday December 14th at a conference to investors and analysts as to why MTLO is a compelling story yet he does not walk the talk and does not own any shares. Is that a fair question?
Read Answer Asked by James on December 14, 2020
Q: Your thoughts on Skylight Health Group please.Thanks.
Read Answer Asked by maurice on December 14, 2020
Q: I have room to add one of these to my TFSA now and another in January. I see 2 of these are in your model portfolios. In what order would you purchase these 3 or am I getting too picky ? SCORE had a huge recent run up; would you wait for it to settle down. I like it’s theme and strong insider ownership Thanks
Derek
Read Answer Asked by Derek on December 11, 2020
Q: What is 5i's opinion on Hello Pal? Is it worth taking a position in it?
Read Answer Asked by Dennis on December 11, 2020
Q: Any thoughts about the We Commerce IPO scheduled for Monday? Seems anything connected to Shopify does well.
Read Answer Asked by David on December 11, 2020
Q: Do you have any thoughts on CleanSpark (CLSK)... I notice that the stock has been moving . Thanks
Tom
Read Answer Asked by Thomas on December 10, 2020
Q: Atara Biotherapeutics (NASDAQ:ATRA) has announced presentation of preclinical data of ATA3219 at American Society of Hematology.
Their allogeneic CAR T-cell therapy targeting CD19, Bayer has also just entered into an exclusive worldwide license agreement, for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors with Atara.
What is your opinion on this company and it's medium and long term investment potential.
Read Answer Asked by Rajesh on December 10, 2020